Baxter to provide sterile manufacturing, packaging for Moderna's COVID-19 vaccine

Baxter International Inc. announced Monday an agreement with Moderna Inc. , in which Baxter will provide sterile manufacturing services and supply packaging for 60 million to 90 million doses of Moderna's COVID-19 vaccine. Baxter's stock is little changed in premarket trading, while Moderna shares fell 1.4%.